Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

5.4

Margin Of Safety %

Put/Call OI Ratio

0.07

EPS Next Q Diff

0.11

EPS Last/This Y

-0.37

EPS This/Next Y

0.23

Price

3.31

Target Price

6

Analyst Recom

2

Performance Q

12.97

Relative Volume

0.4

Beta

0.47

Ticker: OSUR




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-08-15OSUR2.770.070.001735
2025-08-18OSUR2.810.060.001484
2025-08-19OSUR2.80.060.001485
2025-08-20OSUR2.90.060.001495
2025-08-21OSUR2.860.060.001498
2025-08-22OSUR30.060.001499
2025-08-25OSUR3.150.060.001506
2025-08-26OSUR3.490.060.001565
2025-08-27OSUR3.340.060.801576
2025-08-28OSUR3.30.070.001605
2025-08-29OSUR3.320.070.001609
2025-09-02OSUR3.370.070.001621
2025-09-03OSUR3.140.070.001621
2025-09-04OSUR3.150.070.501617
2025-09-05OSUR3.230.070.001619
2025-09-08OSUR3.260.070.001627
2025-09-09OSUR3.370.070.001637
2025-09-10OSUR3.270.070.001637
2025-09-11OSUR3.330.070.001640
2025-09-12OSUR3.310.070.001639
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-08-15OSUR2.77-1464.2- -0.63
2025-08-18OSUR2.81-1342.8- -0.63
2025-08-19OSUR2.80-1342.8- -0.63
2025-08-20OSUR2.90-1342.8- -0.63
2025-08-21OSUR2.86-1342.8- -0.63
2025-08-22OSUR3.00-1342.8- -0.63
2025-08-25OSUR3.15-1342.8- -0.63
2025-08-26OSUR3.48-1342.8- -0.63
2025-08-27OSUR3.34-1342.8- -0.63
2025-08-28OSUR3.29-1342.8- -0.63
2025-08-29OSUR3.31-1342.8- -0.63
2025-09-02OSUR3.36-1342.8- -0.63
2025-09-03OSUR3.15-1342.8- -0.63
2025-09-04OSUR3.15-1342.8- -0.63
2025-09-05OSUR3.23-1342.8- -0.63
2025-09-08OSUR3.25-1342.8- -0.63
2025-09-09OSUR3.37-1342.8- -0.63
2025-09-10OSUR3.27-1342.8- -0.63
2025-09-11OSUR3.32-1342.8- -0.63
2025-09-12OSUR3.31-1342.8- -0.63
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-08-15OSUR6.94-7.415.64
2025-08-18OSUR6.94-10.695.64
2025-08-19OSUR6.97-10.695.64
2025-08-20OSUR6.97-10.695.64
2025-08-21OSUR6.97-10.695.64
2025-08-22OSUR6.97-10.695.64
2025-08-25OSUR6.97-0.875.64
2025-08-26OSUR6.97-0.875.64
2025-08-27OSUR6.97-0.875.33
2025-08-28OSUR1.14-0.875.33
2025-08-29OSUR1.14-0.875.33
2025-09-02OSUR1.14-0.835.33
2025-09-03OSUR1.14-0.835.33
2025-09-04OSUR0.00-0.835.33
2025-09-05OSUR0.00-0.835.33
2025-09-08OSUR0.00-0.565.33
2025-09-09OSUR0.00-0.565.33
2025-09-10OSUR0.00-0.565.33
2025-09-11OSUR0.00-0.565.40
2025-09-12OSUR0.00-0.565.40
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-0.23

Avg. EPS Est. Current Quarter

-0.14

Avg. EPS Est. Next Quarter

-0.12

Insider Transactions

Institutional Transactions

-0.56

Beta

0.47

Average Sales Estimate Current Quarter

28

Average Sales Estimate Next Quarter

31

Fair Value

Quality Score

36

Growth Score

30

Sentiment Score

61

Actual DrawDown %

81.4

Max Drawdown 5-Year %

-84.8

Target Price

6

P/E

Forward P/E

PEG

P/S

1.75

P/B

0.64

P/Free Cash Flow

EPS

-0.68

Average EPS Est. Cur. Y​

-0.63

EPS Next Y. (Est.)

-0.4

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-36.84

Relative Volume

0.4

Return on Equity vs Sector %

-38.3

Return on Equity vs Industry %

-22.2

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.1

EBIT Estimation

OraSure Technologies, Inc.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 501
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic and specimen collection devices and products in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. The company also provides genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; and Colli-Pee collection devices for the volumetric collection of void urine samples. In addition, it provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; OMNIgene SALIVA DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Further, the company offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Additionally, it develops a molecular self-test for chlamydia trachomatis and neisseria gonorrhoeae. The company sells its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.
stock quote shares OSUR – OraSure Technologies, Inc. Stock Price stock today
news today OSUR – OraSure Technologies, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch OSUR – OraSure Technologies, Inc. yahoo finance google finance
stock history OSUR – OraSure Technologies, Inc. invest stock market
stock prices OSUR premarket after hours
ticker OSUR fair value insiders trading